GSK

GSK plc Sponsored ADR · NYSE

Sector Health Technology
Industry Pharmaceuticals: Major
Website gsk.com
Employees(FY) 69400
ISIN US37733W2044

Performance

+2.48%

+0.62%

-8.74%

-9.94%

+1.33%

YTD

-8.79%

Profile

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Advanced Technical Analysis

Technical Analysis of GSK 2025-01-23

The stock indicators reflect a generally bullish sentiment, with the Moving Average Score at 63 indicating strong upward momentum, while the Oscillators Score of 56 and Technical Score of 60 suggest a neutral to positive outlook. Overall, these scores imply a favorable market environment, though caution may be warranted due to the mixed signals ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of GSK

Stock Rank

Recent News & Updates

2025-01-21 13:43
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer(Benzinga)
2025-01-20 11:29
Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?(Insider Monkey)
2025-01-18 08:20
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks(TipRanks)
2025-01-17 09:46
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations(Yahoo Finance)
2025-01-16 15:23
Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?(Insider Monkey)
2025-01-13 16:06
Healthcare M&A poised for a rebound in 2025(Yahoo Finance Video)
2025-01-13 13:57
GSK CEO on US Expansion, M&A, Drug Pipeline, Trump(Bloomberg)
2025-01-13 11:25
Moderna cuts sales forecast on weaker vaccine demand(Yahoo Finance)
2025-01-13 02:05
GSK Enters Agreement to Acquire IDRx, Inc.(Business Wire)
2025-01-12 23:39
GSK CEO on acquisition of biotech firm IDRx(Youtube)
2025-01-12 13:05
GSK Enters Agreement to Acquire IDRx, Inc.(Businesswire)
2025-01-06 10:37
Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?(Insider Monkey)
2025-01-04 07:47
GSK’s Nucala Gains Approval in China for CRSwNP(TipRanks)
2025-01-03 08:15
GSK's Sinus Disease Drug Secures Approval In China(Benzinga)
2024-12-30 01:49
Can GSK plc (LON:GSK) Maintain Its Strong Returns?(Simply Wall St.)
2024-12-25 20:00
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook(Globenewswire)
2024-12-17 19:45
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic and Anal Cancers(Globenewswire)
2024-12-17 07:35
GSK announces CHMP of the EMA recommended expanding approval of Jemperli(TipRanks)
2024-12-17 07:30
GSK announces FDA granted BTD for Jemperli(TipRanks)
2024-12-17 04:10
GSK’s lung cancer therapy gains EMA PRIME designation(Pharmaceutical Technology)
2024-12-10 13:14
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex(Benzinga)
2024-12-09 13:38
Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse(Business Wire)
2024-12-09 00:38
Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse(Businesswire)
2024-12-03 01:07
GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago(Simply Wall St.)
2024-12-02 07:45
Analyst Report: GSK plc(Morningstar Research)
2024-11-25 10:29
GSK gains approval in Japan for extended indication of RSV vaccine(Pharmaceutical Technology)
2024-11-23 06:40
GSK announces Japan’s MHLW approved application to extend indication of Arexvy(TipRanks)
2024-11-19 13:24
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients(Benzinga)
2024-11-18 07:30
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer(GlobeNewswire)
2024-11-18 00:42
Analyst Report: GSK plc(Morningstar Research)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.